文献速递运动医学关节外科

富血小板血浆增强半月板修复在前交叉韧带重建中的效果

Platelet-Rich Plasma Augmentation of Meniscal Repair in the Setting of Anterior Cruciate Ligament Reconstruction.
PubMed 文献 · Am J Sports Med · 2021-09-03

本研究为回顾性配对病例对照研究,纳入2013至2017年单术者数据库1014例初次前交叉韧带重建合并半月板修复患者中的324例(PRP组162例,对照组162例),配对因素为年龄、性别、移植物类型和半月板损伤。2年随访时,PRP组与对照组在SANE膝关节功能评分、IKDC评分、功能表现测试和恢复活动时间上均无差异,但PRP组术后膝关节活动度丢失率更高(13.6% vs 4.6%,P < .001)。结论认为术中PRP未改善膝关节功能,且可能对恢复活动度有负面影响,手术时应谨慎考虑使用PRP。

要点

  • PRP组术后膝关节活动度丢失率高于对照组(13.6% vs 4.6%,P<.001)。
  • PRP未改善IKDC评分、功能表现测试或恢复活动时间。

核心结论

  • 术中PRP未改善前交叉韧带重建合并半月板修复患者的自报膝关节功能、功能表现和恢复活动时间。
  • PRP使用可能与术后膝关节活动度恢复不良相关。
  • 基于这些数据,手术医生在规划膝关节关节内损伤手术时应谨慎考虑PRP的应用。

研究设计与样本

  • 回顾性配对病例对照研究,证据等级3级。
  • 使用2013至2017年单术者数据库,共1014例初次前交叉韧带重建合并半月板修复患者,最终324例符合标准(PRP组162例,对照组162例)。
  • 配对因素为年龄、性别、移植物类型和半月板损伤。
  • 2年时进行SANE评估和损伤监测。

主要发现

  • 功能表现测试两组无差异(P > .05)。
  • PRP组术后膝关节活动度丢失率高于对照组(13.6% vs 4.6%,P < .001)。

关键数值与推荐

  • 主要结局为2年SANE膝关节功能评分。
  • 次要结局包括恢复活动时间(月)、IKDC评分、功能表现测试(膝关节活动度、单腿平衡、单腿跳跃、敏捷性测试)和术后并发症(移植物失败、感染、活动度丢失需再次关节镜粘连松解、静脉血栓等)。

临床怎么用

  • 在前交叉韧带重建合并半月板修复手术中,术中PRP未显示出功能获益。
  • 应警惕PRP可能增加术后膝关节活动度丢失的风险。
  • 手术决策时应谨慎考虑PRP的应用。

局限性

  • 回顾性研究设计,证据等级3级。
  • 单术者数据库,可能限制外推性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The increasing incidence of anterior cruciate ligament (ACL) and meniscal injuries has led to strong interest in discovering new methods to enhance the biological healing response of these tissues. Platelet-rich plasma (PRP) contains various growth factors associated with a positive healing response, but few existing clinical studies are available to determine the risks and benefits of these therapies. PURPOSE: To determine the effects of intraoperative PRP on postoperative knee function and complications at 2 years after ACL reconstruction with meniscal repair. STUDY DESIGN: Cohort study; Level of evidence, 3. METHODS: A retrospective matched case-control study was conducted between 2013 and 2017 using a single surgeon database of 1014 patients undergoing primary ACL reconstruction with concomitant meniscal repair, resulting in 324 patients (162 PRP patients and 162 control patients) who met the study criteria. Patients were matched by age, sex, graft type, and meniscal injury. The Single Assessment Numeric Evaluation (SANE) was administered at 2 years, and injury surveillance was conducted. Secondary outcomes included the time to return to activity (months), self-reported knee function (International Knee Documentation Committee [IKDC] score), functional performance testing (knee range of motion, single-leg balance, single-leg hopping, agility testing), and postoperative complications (graft failure, infection, loss of motion [requiring repeat arthroscopy for lysis of adhesions], venous thrombosis, etc). Univariate models were used for between-group comparisons, and alpha was set at .05 for all analyses. RESULTS: No differences were found in SANE knee function scores between the PRP and matched-control groups at 2 years (91.6 ± 11.2 vs 92.4 ± 10.6, respectively; P = .599). Additionally, no differences were reported between groups for self-reported function (IKDC score, 87.6 ± 13.3 vs 88.1 ± 12.6; P = .952), functional performance testing (P > .05), and timing of return to activity (7.8 ± 1.9 vs 8.0 ± 1.9 months; P = .765). The PRP group demonstrated a higher rate of postoperative knee motion loss compared with the control group (13.6% vs 4.6%; P < .001). No other differences were observed in postoperative complications (P > .05). CONCLUSION: The added use of intraoperative PRP did not improve self-reported knee function, functional performance, and timing of return to activity for patients undergoing ACL reconstruction with meniscal repair. Furthermore, the use of PRP may have negative consequences for regaining knee range of motion after surgery. On the basis of these data, surgeons should cautiously consider the application of PRP when planning surgery for intra-articular injuries of the knee. REGISTRATION: NCT03704376 (ClinicalTrials.gov identifier).

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Bailey L, Weldon M, Kleihege J, et al. Platelet-Rich Plasma Augmentation of Meniscal Repair in the Setting of Anterior Cruciate Ligament Reconstruction. Am J Sports Med. 2021. PMID: 34477016. doi:10.1177/03635465211036471

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。